Feb
28
2018
Better Biobanking a Best Bet for Rare Disease Research
Editor’s Note: Families facing a rare disease diagnosis often do not know where to turn first in their search for the most advanced treatments and potentially a cure for their children. Only 5 percent of rare diseases have a treatment approved by the Food and Drug Administration, according to the National Organization for Rare Disorders. This is due in part to the lack of high quality biospecimens for research.
Yippee! Hooray! Woo-hoo! We’d like to take a few moments to celebrate the recent accolades given to scientists and physician researchers at The Children’s Hospital of Philadelphia Research Institute who are featured in the latest issue of Bench to Bedside, our monthly newsmagazine.